| (2) CELL-LINE | (1) CERVIX | (4) OTHER | (1) SKIN |
| ATTGAATTTGTGCAAAATTACTGATGGCCAATTCAGTGGAAGGGAAGGGAAATCTTGTTATTCCTATTCCAGAATCTCTTCCTGATTTCCTCATTTGATTCTTTCACGCCTTGGGGTAGGGGAGGGGAATGCATTCGCGGCTCTATAAAGAATTGTCCTTATTTTCGAACTTTCTCCCTGGTCACACATGGCTCCCTCAGAGGAAGACACAGCACCCTGGAGATGTTAAGGCAGAAGTCAGTTCTTCTGT ..........................................................................(((((((((.....(((((..(((.....))).....)))))...)))))))))........(((..(((....)))..))).............................................................................................. ........................................................................73............................................................................................167................................................................................. | Size | Perfect hit | Total Norm | Perfect Norm | SRR189782 | SRR189783 | SRR330895(SRX091733) tissue: skin psoriatic uninvolveddisease stat. (skin) | SRR189784 | SRR039192(GSM494811) K562 cell line is derived from a CML patient . (cell line) | SRR039635(GSM518472) THP1_nuc_sRNAs. (cell line) | SRR343335 | SRR040015(GSM532900) G623T. (cervix) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| .................................................................................................................................................TAAAGAATTGTCCTTTTG....................................................................................... | 18 | 76.00 | 0.00 | 74.00 | 2.00 | - | - | - | - | - | - | |
| .................................................................................................................................................TAAAGAATTGTCCTTTAG....................................................................................... | 18 | 2.00 | 0.00 | 2.00 | - | - | - | - | - | - | - | |
| .................................................................................................................................................TAAAGAATTGTCCTTTGG....................................................................................... | 18 | 2.00 | 0.00 | 2.00 | - | - | - | - | - | - | - | |
| .............................................................................CTTCCTGATTTCCTCGC............................................................................................................................................................ | 17 | 1.00 | 0.00 | - | - | - | 1.00 | - | - | - | - | |
| .................................................................................................................................................TAAAGAATTGTCCTTTTTG...................................................................................... | 19 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - | |
| .................................................................................................................................................TAAAGAATTGTCCTTTTGG...................................................................................... | 19 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - | |
| ................................................................................................................................................................ATTTTCGAACTTTCTCCCTG...................................................................... | 20 | 1 | 1.00 | 1.00 | - | - | - | - | - | 1.00 | - | - |
| ...............................................................................................................TGGGGTAGGGGAGGGGATAG....................................................................................................................... | 20 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - | |
| .................................................................................................................................................TAAAGAATTGTCCTTTTA....................................................................................... | 18 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - | |
| ..........TGCAAAATTACTGATTTC.............................................................................................................................................................................................................................. | 18 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - | |
| .....................................................................CAGAATCTCTTCCTGATTTCCTCAT............................................................................................................................................................ | 25 | 1 | 1.00 | 1.00 | - | - | - | - | 1.00 | - | - | - |
| .................................................................................................................................................TAAAGAATTGTCCTTTGT....................................................................................... | 18 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - | |
| .................................................................................................................................................TAAAGAATTGTCCTTTCG....................................................................................... | 18 | 1.00 | 0.00 | 1.00 | - | - | - | - | - | - | - |
| ATTGAATTTGTGCAAAATTACTGATGGCCAATTCAGTGGAAGGGAAGGGAAATCTTGTTATTCCTATTCCAGAATCTCTTCCTGATTTCCTCATTTGATTCTTTCACGCCTTGGGGTAGGGGAGGGGAATGCATTCGCGGCTCTATAAAGAATTGTCCTTATTTTCGAACTTTCTCCCTGGTCACACATGGCTCCCTCAGAGGAAGACACAGCACCCTGGAGATGTTAAGGCAGAAGTCAGTTCTTCTGT ..........................................................................(((((((((.....(((((..(((.....))).....)))))...)))))))))........(((..(((....)))..))).............................................................................................. ........................................................................73............................................................................................167................................................................................. | Size | Perfect hit | Total Norm | Perfect Norm | SRR189782 | SRR189783 | SRR330895(SRX091733) tissue: skin psoriatic uninvolveddisease stat. (skin) | SRR189784 | SRR039192(GSM494811) K562 cell line is derived from a CML patient . (cell line) | SRR039635(GSM518472) THP1_nuc_sRNAs. (cell line) | SRR343335 | SRR040015(GSM532900) G623T. (cervix) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| .........................................................................................................................................................................................................CCAGGGTGCTGTGTCTTCC.............................. | 19 | 1 | 2.00 | 2.00 | - | - | 2.00 | - | - | - | - | - |
| .TTGAATTTGTGCAAAATG....................................................................................................................................................................................................................................... | 18 | 1.00 | 0.00 | - | - | - | - | - | - | 1.00 | - | |
| ..................................................................................TGATTTCCTCATTTGACCCA.................................................................................................................................................... | 20 | 1.00 | 0.00 | - | - | - | - | - | - | - | 1.00 |